Transition to Ambulatory Bariatric Surgery (TABS) Trial

This study, called the TABS Trial, is looking at whether it's safe and practical for patients to go home the same day after bariatric surgery (weight-loss surgery like sleeve gastrectomy or gastric bypass). You would be randomly assigned to either go home within 6 hours of recovery or stay at least one night in the hospital. The main goal is to see how often people in each group need to visit the emergency room within 7 days of their surgery. This study is currently unclear on its recruitment status, but plans to enroll 200 participants. To join, you must be between 25 and 55 years old, have a BMI of 60 or less, and be having bariatric surgery at the sponsor's site. Certain health conditions, like Type 1 Diabetes or severe sleep apnea, would prevent you from participating.

Study design
This is a randomized study, meaning you have an equal chance of being in either the same-day discharge group or the overnight stay group. It is an open-label trial, so both you and the study team will know which group you are in. The study plans to enroll 200 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome measures emergency department visits from baseline to seven days after surgery. The study also compares 30-day charges.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07011628

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Not Yet Recruiting
NAAges 25–55InterventionalTreatment
Vanderbilt University Medical Center
~200 participants
Updated 2026-08-18 on ClinicalTrials.gov
What's tested:Same Day Discharge

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Emergency Department Visits
Measured over baseline to seven days
Obesity and Obesity-related Medical Conditions
Bariatric Surgery
1 sites across 1 states
Tennessee1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

BMI ≤ 60 kg/m2
Primary Sleeve gastrectomy or Gastric Bypass,
Undergoing bariatric surgery at sponsor site

Exclusion

Type 1 Diabetes
Myocardial Infarction
Unstable Angina or Heart Failure
Prior Stroke
Solid organ transplantation
Systemic glucocorticoid prior 28 days
Severe Obstructive Sleep Apnea
Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90)
Untreated Hyperthyroidism
Chronic Kidney Disease (EGFR \< 60)
Current anticoagulant use,
Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%)
Chronic opioid use
Insulin dependence.
Need for extended venous thromboembolic event prophylaxis,
\> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
Patient lives \> 130 miles from the hospital.
Tobacco use in last 12 months
Desire to become pregnant or active pregnancy
Prisoners
Unable or unwilling to follow-up
Unable to understand or provide consent
  • Emergency Department Visitsbaseline to seven days

    Number of emergency room visits after surgery